The Beauty Health Company (SKIN) Reports Q3 Loss, Tops Revenue Estimates
Portfolio Pulse from
The Beauty Health Company (SKIN) reported a Q3 loss of $0.15 per share, which was larger than the Zacks Consensus Estimate of a $0.12 loss. This is a decline from the $0.05 earnings per share reported a year ago. However, the company exceeded revenue expectations.
November 13, 2024 | 12:00 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
The Beauty Health Company reported a larger-than-expected Q3 loss of $0.15 per share, missing the Zacks Consensus Estimate. However, the company exceeded revenue expectations.
The larger-than-expected loss per share is likely to negatively impact SKIN's stock price in the short term, despite exceeding revenue expectations. Investors may react to the earnings miss.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100